首页> 美国卫生研究院文献>Cancer Biology Medicine >Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases

【2h】

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases

机译：紫杉醇-依托泊苷-卡铂/顺铂与依托泊苷-卡铂/顺铂一线治疗合并小细胞肺癌：62例回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo compare the efficacy and adverse effects of paclitaxel-etoposide-carboplatin/cisplatin (TEP/TCE) regimen with those of etoposide-carboplatin/cisplatin (EP/CE) regimen as first-line treatment for combined small-cell lung cancer (CSCLC).

机译：目的比较紫杉醇-依托泊苷-卡铂/顺铂（TEP / TCE）方案与依托泊苷-卡铂/顺铂（EP / CE）方案作为一线治疗小细胞肺癌的疗效和不良反应。

著录项

期刊名称 Cancer Biology Medicine
作者
Yue-Ya Li; Chan Zhou; Deng-Xia Yang; Jing Wang; Zhu-Jun Liu; Xin-Yue Wang; Kai Li;
展开▼
作者单位

展开▼
年(卷),期 2015(12),2
年度 2015
页码 117–125
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
入库时间 2022-08-17 13:15:40

相似文献

外文文献
中文文献
专利

1. Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide- carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer： a retrospective analysis of 62 cases [J] . Yue-Ya Li, Chan Zhou, Deng-Xia Yang, 癌症生物学与医学：英文版 . 2015,第002期

机译：紫杉醇-依托泊苷-卡铂/顺铂与依托泊苷-卡铂/顺铂一线治疗合并小细胞肺癌：62例回顾性分析
2. Randomized Phase III Study of Docetaxel Plus Cisplatin Versus Pemetrexed Plus Cisplatin as First-line Treatment of Nonsquamous Non–Small-cell Lung Cancer: A TRAIL Trial [J] . Cheol-Kyu Park, In-Jae Oh, Kyu-Sik Kim, Clinical lung cancer . 2017,第4期

机译：Docetaxel Plus顺铂的随机期III研究与Pemetrexed Plus顺铂作为Nonsquous非小细胞肺癌的一线治疗：追踪试验
3. Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer [J] . Yan Sun, Ying Cheng, Xuezhi Hao, BMC Cancer . 2016,第1期

机译：氨柔比星/顺铂与依托泊苷/顺铂作为广泛的小细胞肺癌的一线治疗的随机III期试验
4. The effect of ammonium chloride on the apoptosis induced by cisplatin in human lung cancer A549 cells [C] . Ye Xu, Ning Wang, Yan Ding, International Forum on Materials Science and Industrial Technology . 2013

机译：氯化铵对人肺癌顺铂诱导凋亡的影响A549细胞
5. Predictive factors of the treatment outcome in patients with advanced biliary tract cancer receiving gemcitabine plus cisplatin as first-line chemotherapy [D] . 鈴木, 裕子 2019

机译：吉西他滨联合顺铂一线化疗对晚期胆道癌患者治疗效果的预测因素
6. Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer [O] . Yan Sun, Ying Cheng, Xuezhi Hao, 2016

机译：氨柔比星/顺铂与依托泊苷/顺铂作为广泛的小细胞肺癌的一线治疗的随机III期试验
7. Randomized phase III trial of amrubicin/cisplatin versus etoposide/cisplatin as first-line treatment for extensive small-cell lung cancer [O] . 2016

机译：氨柔比星/顺铂与依托泊苷/顺铂作为广泛的小细胞肺癌的一线治疗的随机III期试验

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases

摘要

著录项

相似文献

相关主题

期刊订阅